Cystic Fibrosis Foundation and SPRIN-D led a €35m Series B round in SNIPR.

Cystic Fibrosis Foundation, a nonprofit organization focused on curing cystic fibrosis, and SPRIN-D, an innovation agency created by the German government to turbocharge groundbreaking, high-impact technologies, led a €35m Series B round in SNIPR, a B2B technology company, with participation from Lundbeckfonden BioCapital, North-East Family Office and Wellington Partners. "This financing marks a pivotal milestone for SNIPR BIOME as we advance the clinical development of SNIPR001 for the prevention of blood stream infections and continue to expand our infectious disease pipeline targeting pathogens of critical importance," Christian Grøndahl, CEO and Co-Founder of SNIPR BIOME.